Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,998 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma.
Piao L, Mukherjee S, Chang Q, Xie X, Li H, Castellanos MR, Banerjee P, Iqbal H, Ivancic R, Wang X, Teknos TN, Pan Q. Piao L, et al. Among authors: mukherjee s. Oncotarget. 2016 Jul 16;8(36):60025-60035. doi: 10.18632/oncotarget.10620. eCollection 2017 Sep 1. Oncotarget. 2016. PMID: 28947951 Free PMC article.
Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression.
Mukherjee S, Debata PR, Hussaini R, Chatterjee K, Baidoo JNE, Sampat S, Szerszen A, Navarra JP, Fata J, Severinova E, Banerjee P, Castellanos MR. Mukherjee S, et al. Oncotarget. 2017 Mar 29;8(37):60904-60916. doi: 10.18632/oncotarget.16648. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977833 Free PMC article.
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors.
Mukherjee S, Hussaini R, White R, Atwi D, Fried A, Sampat S, Piao L, Pan Q, Banerjee P. Mukherjee S, et al. Cancer Immunol Immunother. 2018 May;67(5):761-774. doi: 10.1007/s00262-018-2130-3. Epub 2018 Feb 16. Cancer Immunol Immunother. 2018. PMID: 29453519 Free PMC article.
6,998 results